Richard Pops Net Worth & Insider Trades

Richard Pops - Director, Neurocrine Biosciences Inc

As of January 5, 2023

What is Richard Pops's Net Worth?

The current estimated net worth of Neurocrine Biosciences Inc's Director, Richard Pops, is estimated to be about $159.35M . Richard Pops owns about 29,512 units of Neurocrine Biosciences Inc common stock. In the last 20 years at Neurocrine Biosciences Inc, Richard Pops has sold an estimated value of $6.82M worth.

What is Richard Pops's Past Insider Trading?

Richard Pops's largest purchase order was 15,000 units , worth over $190.65K on January 5, 2023. Richard Pops's largest sale order was 15,000 units , worth over $1.79M on January 5, 2023. In total, Richard Pops has made about 35 transactions over 20 years of their time at Neurocrine Biosciences Inc. Richard Pops usually trades in May, with the busiest year in 2018.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

What was Richard Pops's Salary in 2020?

As Director of Neurocrine Biosciences Inc, Richard Pops has a total base salary of $1,073,712 . Richard Pops received compensation valued at about $8,041,702 in 2020 after becoming Director. The vast majority of their compensation came in the form of option awards of $3,489,121 , stock awards of $2,551,714 , and other compensation of $14,500 .

What is Richard Pops's' Mailing Address?

  • Mailing address is 10555 Science Center Dr San Diego CA 92121 CA

Neurocrine Biosciences Inc Executive Compensation

Name
Year
Salary
Bonus
Option Awards
Stock Awards
Other Compensation
Total
Kevin C. Gorman, Ph.D. 2018 $675,000 $425,250 $4,486,852 $2,998,832 $47,045 $8,632,979
Kevin C. Gorman, Ph.D. 2019 $725,000 $667,000 $6,000,525 $2,000,071 $58,230 $9,450,826
Kevin C. Gorman, Ph.D. 2020 $775,000 $542,500 $7,124,633 $5,375,188 $63,311 $13,880,632
Matthew C. Abernethy 2018 $420,000 $199,500 - $1,996,506 $69,741 $2,685,747
Matthew C. Abernethy 2019 $495,600 $284,970 $3,750,345 $1,250,035 $42,170 $5,823,120
Matthew C. Abernethy 2020 $545,200 $190,820 $2,999,869 $2,500,266 $45,021 $6,281,176
Eric Benevich 2018 $432,600 $205,485 $1,496,335 $1,499,417 $38,768 $3,672,605
Eric Benevich 2019 $467,200 $280,320 $3,750,345 $1,250,035 $45,547 $5,793,447
Eric Benevich 2020 $499,900 $199,960 $2,999,869 $3,000,257 $48,974 $6,748,960
Kyle W. Gano, Ph.D. 2018 $403,100 $191,473 $1,309,024 $2,656,575 $8,069 $4,568,241
Kyle W. Gano, Ph.D. 2019 $443,400 $266,040 $3,000,285 $1,000,076 $16,171 $4,725,972
Kyle W. Gano, Ph.D. 2020 $487,700 $207,273 $3,749,799 $2,750,210 $16,751 $7,211,733
Eiry W. Roberts, M.D. 2018 $490,700 $220,800 $2,863,700 $4,053,869 $671,554 $8,300,623
Eiry W. Roberts, M.D. 2019 $538,200 $309,465 $3,000,285 $1,000,076 $51,889 $4,899,915
Eiry W. Roberts, M.D. 2020 $575,900 $215,963 $2,624,855 $2,375,242 $56,073 $5,848,033
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/914475/000119312521111693/d87247ddef14a.htm

What are Neurocrine Biosciences Inc's Past Insider Trades?

Neurocrine Biosciences Inc's most recent insider trade came on February 8, 2023 by Julie Cooke who sold 17,079 units worth $1.76M . In the last 20 years, insiders at Neurocrine Biosciences Inc have sold an estimated value of $400.2M and bought an estimated value of $67.75M worth of shares. Insider trading is most common in February, with the busiest year in 2017. The most active traders at the company are Dimitri Grigoriadis, Chief Research Officer,  Gary Lyons, Director,  and Haig Bozigian, Chief Development Officer .

NEUROCRINE BIOSCIENCES INC Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...